We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

75 hedge funds and large institutions have $533M invested in Dyne Therapeutics in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 11

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

9% more funds holding

Funds holding: 69 → 75 (+6)

2.26% more ownership

Funds ownership: 64.47% → 66.73% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

13% less capital invested

Capital invested by funds: $614M → $533M (-$81.8M)

Holders
75
Holders Change
+6
Holders Change %
+8.7%
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
34
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$31M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$17.1M
3
CC
Commodore Capital
New York
+$8.32M
4
HA
HHLR Advisors
Cayman Islands
+$7.74M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.83M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$11.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.2M
3
PA
Perceptive Advisors
New York
-$8.4M
4
CCM
CAAS Capital Management
New York
-$3.18M
5
WP
Woodline Partners
California
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
26
EcoR1 Capital
California
$3.34M – – –
Fidelity Investments
27
Fidelity Investments
Massachusetts
$3.28M +$1.82M +93,883 +80%
Northern Trust
28
Northern Trust
Illinois
$2.72M +$254K +13,135 +8%
SCM
29
Soleus Capital Management
Connecticut
$2.71M +$3.37M +174,360 New
ACM
30
Altium Capital Management
New York
$2.59M +$3.22M +166,636 New
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$1.95M +$910K +47,000 +60%
Charles Schwab
32
Charles Schwab
California
$1.9M +$778K +40,216 +49%
HMC
33
Harvard Management Company
Massachusetts
$1.67M – – –
Goldman Sachs
34
Goldman Sachs
New York
$1.59M +$1.12M +57,794 +129%
ACH
35
ArrowMark Colorado Holdings
Colorado
$1.55M – – –
CS
36
Credit Suisse
Switzerland
$1.5M +$1.15M +59,520 +160%
IBT
37
International Biotechnology Trust
United Kingdom
$1.45M +$1.82M +93,886 New
MS
38
Maven Securities
Jersey
$1.39M +$1.77M +91,562 New
Tudor Investment Corp
39
Tudor Investment Corp
Connecticut
$1.15M +$1.22M +62,992 +585%
TRSOTSOK
40
Teachers Retirement System of the State of Kentucky
Kentucky
$962K +$913K +47,151 +319%
N
41
Nuveen
North Carolina
$644K +$352K +18,190 +78%
Ensign Peak Advisors
42
Ensign Peak Advisors
Utah
$621K – – –
Two Sigma Advisers
43
Two Sigma Advisers
New York
$564K +$230K +11,900 +49%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$445K -$52.5K -2,712 -9%
Two Sigma Investments
45
Two Sigma Investments
New York
$404K +$503K +26,000 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$377K +$53.7K +2,776 +13%
CCM
47
CAAS Capital Management
New York
$336K -$3.18M -164,275 -88%
PCM
48
Pentwater Capital Management
Florida
$233K +$290K +15,000 New
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$228K +$284K +14,682 New
Bank of America
50
Bank of America
North Carolina
$205K +$11K +566 +4%
1
2
3 4

DYN Hedge Fund Activity: Q1 2021 in Review

75 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q1 2021, worth a combined $533M — down 13% from $614M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DYN positions and 13 closed out — a net gain of 6 holders — while 34 added to existing stakes and 11 trimmed.

The largest buyer was Logos Global Management, adding an estimated $31M. The largest seller was Franklin Resources, cutting an estimated $11.1M.

  • 75 institutional investors held Dyne Therapeutics (DYN) as of Q1 2021, up from 69 in Q4 2020.
  • Funds reported $533M of Dyne Therapeutics stock for Q1 2021, down 13% quarter-over-quarter.
  • 19 funds opened new Dyne Therapeutics positions in Q1 2021 and 13 closed out, a net change of +6 holders.
  • The largest Dyne Therapeutics buyer in Q1 2021 was Logos Global Management, an estimated $31M added.
  • The largest Dyne Therapeutics seller in Q1 2021 was Franklin Resources, an estimated $11.1M sold.

Based on aggregated 13F filings for Q1 2021.